Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
26,31-03-2022,"BORTIANOR-NEW APLAKU
172/22",82 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M16.12 [Unilateral primary osteoarthritis, left hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,31-03-2022,31-03-2022,,,20,OPD,
47,31-03-2022,AMANFROM -GALIEA,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID w/meals |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",TRADER,,31-03-2022,31-03-2022,,,20,OPD,32178/19
77,31-03-2022,MADINA-NEW RD,71 Year(s),Female,DERMATOLOGY CLINIC,Derma Review Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","L23.9 [Allergic contact dermatitis, unspecified cause]  ==> OLD, R73.9 [Hyperglycaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], TETMOSOL SOAP[ TETMOSOL SOAP |  | Soap | BDS |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TETMOSOL SOAP[ TETMOSOL SOAP |  | Soap ]",,,31-03-2022,31-03-2022,,,20,OPD,
141,31-03-2022,"GBAWE , TELECOM",70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ],GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ],,,31-03-2022,31-03-2022,,,60,OPD,
181,31-03-2022,TUBA-ADDO MOSQUAE,85 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"H02.862 [Hypertrichosis of right lower eyelid]  ==> OLD, M16.12 [Unilateral primary osteoarthritis, left hip]  ==> OLD, B35.3 [Tinea pedis]  ==> NEW",No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], GRISEOFULVIN TABLET[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], DIPROSON [ DIPROSON  | 0.05% 30G | Lotion | BID |  For 5 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], GRISEOFULVIN TABLET[ GRISEOVULFIN | 500MG | Tablet ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], DIPROSON [ DIPROSON  | 0.05% 30G | Lotion ]",,,31-03-2022,31-03-2022,,,20,OPD,30043/20
192,31-03-2022,awoshie ,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 60 Days  ], ACECLOFENAC(ZULU)[ ACECLOFENAC(ZULU) | 100MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], ACECLOFENAC(ZULU)[ ACECLOFENAC(ZULU) | 100MG | Tablet ]",TRADER,,31-03-2022,31-03-2022,,,20,OPD,
370,31-03-2022,"GBAWE , TELECOM",70 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Insured,,,,,31-03-2022,31-03-2022,,,10,OPD,
412,31-03-2022,tetegu,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,31-03-2022,31-03-2022,,,20,OPD,
575,31-03-2022,MALLAM,55 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome, NEWLY DIAGNOSED HYPERGLYCAEMIA IN DM/DKA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection | Stat |  For 1 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | PRN |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,31-03-2022,31-03-2022,,,50,OPD,
653,30-03-2022,ABLEKUMAH-PENTECOST PRAYER CAMP,70 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"M10.09 [Idiopathic gout, multiple sites]  ==> NEW, E78.70 [Disorder of bile acid and cholesterol metabolism, unspecified]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | Daily |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,,,30-03-2022,30-03-2022,,,10,OPD,
750,30-03-2022,awutu breku,48 Year(s),Female,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","L30.3 [Infective dermatitis]  ==> NEW, N34.1 [Nonspecific urethritis]  ==> NEW",No,Insured,"CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 5 Days  ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet | Daily |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], METRONIDAZOLE GEL[ METROGEL | 20G | Gel | BDS |  For 14 Days  ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], ACTIVE LIFE[ ACTIVE LIFE |  |  | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], METRONIDAZOLE GEL[ METROGEL | 20G | Gel ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule ], ACTIVE LIFE[ ACTIVE LIFE |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,30-03-2022,30-03-2022,,,20,OPD,
891,30-03-2022,weija ,43 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,30-03-2022,30-03-2022,,,20,OPD,
912,30-03-2022,SENTA MARIA. DESERET HOSPITAL,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, F06.4 [Organic anxiety disorder]  ==> NEW, R00.0 [Tachycardia, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet ]",TRADER,,30-03-2022,30-03-2022,,,20,OPD,
924,30-03-2022,BUBIASHIE-BEHIND ACADEMY,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,Unemployed,,30-03-2022,30-03-2022,,,20,OPD,29326/21
959,30-03-2022,"OBLOGO, WAREHOUSE",63 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,30-03-2022,30-03-2022,,,10,OPD,
1194,30-03-2022,MCCARTHY DOWN,54 Year(s),Female,,,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> NEW,,No,Non-Insured,"FUROSEMIDE INJECTION[ FUROSEMIDE | 10MG/ML IN 2ML | Injection | Stat |  For 1 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ]",,,,30-03-2022,30-03-2022,,,245,OPD,
1237,29-03-2022,WEIJIA-ATERWKS,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, A54.84 [Gonococcal pneumonia]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMOXICILLIN+CLAVULANIC ACID TABLET[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ]",,,29-03-2022,29-03-2022,,,10,OPD,6835/16 MR-3B-B3-94
1238,29-03-2022,"GBAWE 
NEAR TIM SPOT ",59 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> NEW, A02.25 [Salmonella pyelonephritis]  ==> NEW",No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",WELDER,,29-03-2022,29-03-2022,,,10,OPD,
1272,29-03-2022,"NEW RUSSIA 
DANSOMAN ",51 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule | BID |  For 10 Days  ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet | OD |  For 5 Days  ]","CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet ]",,,29-03-2022,29-03-2022,,,0,OPD,
1293,29-03-2022,gbawe,49 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,29-03-2022,29-03-2022,,,10,OPD,
1321,29-03-2022,odorkor,78 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | OD |  For 30 Days  ]","AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,29-03-2022,29-03-2022,,,10,OPD,
1337,29-03-2022,TETEGU,84 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet ]",,,29-03-2022,29-03-2022,,,20,OPD,
1352,29-03-2022,"AWOSHIE, A-LANG",57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-03-2022,29-03-2022,,,60,OPD,
1355,29-03-2022,kasoa,55 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,29-03-2022,29-03-2022,,,10,OPD,
1378,29-03-2022,kasoa galeliya,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ],ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ],,,29-03-2022,29-03-2022,,,20,OPD,
1380,29-03-2022,MATAHEKO-KUCHACHA,47 Year(s),Female,DERMATOLOGY CLINIC,Derma Review Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","L26. [Exfoliative dermatitis]  ==> NEW, B36.0 [Pityriasis versicolor]  ==> NEW",No,Insured,"KETOCONAZOLE SHAMPOO[ KETOCONAZOLE SHAMPOO | 2% | Lotion | OD |  For 14 Days  ], BETNOVATE CREAM[ BETNOVATE CREAM | 20G | Cream | BDS |  For 14 Days  ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet | Nocte |  For 10 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","KETOCONAZOLE SHAMPOO[ KETOCONAZOLE SHAMPOO | 2% | Lotion ], BETNOVATE CREAM[ BETNOVATE CREAM | 20G | Cream ], CETIRIZINE TABLET[ CETIRIZINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Teacher,,29-03-2022,29-03-2022,,,70,OPD,
1404,29-03-2022,awoshie,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]",,,,29-03-2022,29-03-2022,,,20,OPD,
1468,29-03-2022,anyaa,39 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,29-03-2022,29-03-2022,,,20,OPD,
1596,29-03-2022,"Gbawe
Dzama",38 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",Teacher,,29-03-2022,29-03-2022,,,20,OPD,
1631,29-03-2022,"AGLO FARMS -
TUBA ",49 Year(s),Female,,,,No Outcome,NA ,"E08.3291 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye]  ==> NEW",,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | QID |  For 1 Days  ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  | PRN |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLINDAMYCIN INJECTION[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN INJECTION[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ]",PASTOR,,29-03-2022,29-03-2022,,,10,OPD,
1694,29-03-2022,MATAHEKO-KUCHACHA,47 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,,,Teacher,,29-03-2022,29-03-2022,,,10,OPD,
1698,29-03-2022,gbawe,73 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,29-03-2022,29-03-2022,,,110,OPD,
1812,28-03-2022,"GBAWE 
BULIEMI",71 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, M10.09 [Idiopathic gout, multiple sites]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,28-03-2022,28-03-2022,,,10,OPD,
1830,28-03-2022,"AMANFROM
ZONGO",55 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"E78.70 [Disorder of bile acid and cholesterol metabolism, unspecified]  ==> NEW, E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,28-03-2022,28-03-2022,,,10,OPD,
1865,28-03-2022,"KASOA , KULABULE",81 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"M17.12 [Unilateral primary osteoarthritis, left knee]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, L03.115 [Cellulitis of right lower limb]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | BID |  For 14 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,TRADER,,28-03-2022,28-03-2022,,,10,OPD,
1867,28-03-2022,gbawe zero,48 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,K29.1 [Other acute gastritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | BID |  For 14 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ]",TRADER,,28-03-2022,28-03-2022,,,20,OPD,
1883,28-03-2022,weija,71 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], ATORVASTATIN TABLET 10MG[  | 10MG |  | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], ATORVASTATIN TABLET 10MG[  | 10MG |  ]",,,28-03-2022,28-03-2022,,,10,OPD,
1956,28-03-2022,"ODORKOR
ST ANTHONY",76 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, K85.01 [Idiopathic acute pancreatitis with uninfected necrosis]  ==> OLD, D50.0 [Iron deficiency anaemia secondary to blood loss (chronic)]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], IRON, VITAMINS, MINERALS)[ FERONEW |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], IRON, VITAMINS, MINERALS)[ FERONEW |  | Capsule ]",,,28-03-2022,28-03-2022,,,20,OPD,
2092,28-03-2022,gbawe top base,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,"A15.1 [Tuberculosis of lung, confirmed by culture only]  ==> OLD, E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",No,Insured,TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ],TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ],,,28-03-2022,28-03-2022,,,20,OPD,
2673,26-03-2022,"OBLOGO , TOP BASE",55 Year(s),Female,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDEINFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection | Stat |  For 1 Days  ], CEFUROXIME INJECTION[ CEFUROXIME | 750MG | Injection | Stat |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDEINFUSION 0.9%(500ML)[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection ], CEFUROXIME INJECTION[ CEFUROXIME | 750MG | Injection ]",Unemployed,,26-03-2022,26-03-2022,,,10,OPD,
2735,25-03-2022,AWOSHIE ,60 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, J02.9 [Acute pharyngitis, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], AZITHROMYCIN CAPSULE[ AZITHROMYCIN | 250MG | Tablet | Daily |  For 3 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], AMOXICILLIN+CLAVULANIC ACID TABLET[ AMOKSICLAV | 875MG +125MG | Tablet ], AZITHROMYCIN CAPSULE[ AZITHROMYCIN | 250MG | Tablet ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,25-03-2022,25-03-2022,,,60,OPD,
2748,25-03-2022,BORTIANOR-APLKU,71 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, F06.4 [Organic anxiety disorder]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CLARITHROMYCIN CAPSULE[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 7 Days  ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet | TDS |  For 7 Days  ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAOLE TABLET400MG[ METRONIDAOLE | 400MG | Tablet ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet ]",,,25-03-2022,25-03-2022,,,20,OPD,2255/16
2774,25-03-2022,kasoa tuba,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-03-2022,25-03-2022,,,20,OPD,
2776,25-03-2022,"Anyaa 
New market",49 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,25-03-2022,25-03-2022,,,10,OPD,
2781,25-03-2022,SANTA  MARIA,93 Year(s),Female,,,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,"I27.0 [Primary pulmonary hypertension]  ==> NEW, Z87.11 [Personal history of peptic ulcer disease]  ==> NEW",No,Insured,,,,,25-03-2022,25-03-2022,,,50,OPD,
2788,25-03-2022,mccarthy,74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet ]",,,25-03-2022,25-03-2022,,,20,OPD,
2851,25-03-2022,ablekuman,42 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,25-03-2022,25-03-2022,,,10,OPD,
2860,25-03-2022,"Weija 
Oblogo",74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | TID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 30 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,25-03-2022,25-03-2022,,,20,OPD,
2867,25-03-2022,new bortianor,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, G71.9 [Primary disorder of muscle, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule ]",,,25-03-2022,25-03-2022,,,20,OPD,
2917,25-03-2022,"TABORA 
ISRAEL",7 Year(s),Female,DERMATOLOGY CLINIC,Derma Consultation Child,,No Outcome,NA ,E13.620 [Other specified diabetes mellitus with diabetic dermatitis]  ==> NEW,,No,Insured,BETNOVATE CREAM ()[ BETNOVATE CREAM |  | Tablet | BDS |  For 7 Days  ],,child,,25-03-2022,25-03-2022,,,10,OPD,
2961,25-03-2022,kasoa tuba,72 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Insured,,,,,25-03-2022,25-03-2022,,,10,OPD,
2977,25-03-2022,MALLAM ,50 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ]",,,25-03-2022,25-03-2022,,,60,OPD,
3026,25-03-2022,BUBIASHIE,65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, A01.09 [Typhoid fever with other complications]  ==> NEW, M17.10 [Unilateral primary osteoarthritis, unspecified knee]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet | BID |  For 3 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",TRADER,,25-03-2022,25-03-2022,,,60,OPD,
3037,25-03-2022,"Weija 
Oblogo",74 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,OCULAR HYPERTENSION ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> NEW,,No,Insured,"NORMO TEARS[ HYDROMELLOSE | 10ML | Drops | QID |  For 30 Days  ], TIMOLOL MALEATE EYE DROP 0.5%[ EPITIMOL | 0.05% 5G | Drops | BID |  For 30 Days  ]","NORMO TEARS[ HYDROMELLOSE | 10ML | Drops ], TIMOLOL MALEATE EYE DROP 0.5%[ EPITIMOL | 0.05% 5G | Drops ]",,,25-03-2022,25-03-2022,,,60,OPD,
3041,25-03-2022,upper weija,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> NEW,G89.11 [Acute pain due to trauma]  ==> NEW,No,Insured,"AMOXICILLIN+CLAVULINIC ACID TABLET[ OTHERS | 500MG+100MG | Tablet | BID |  For 5 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ]","AMOXICILLIN+CLAVULINIC ACID TABLET[ OTHERS | 500MG+100MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,25-03-2022,25-03-2022,,,20,OPD,
3234,24-03-2022,TUBA ,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,24-03-2022,24-03-2022,,,20,OPD,
3248,24-03-2022,DANSOMAN ,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, N34.2 [Other urethritis]  ==> NEW, B33.0 [Epidemic myalgia]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet | BID |  For 7 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | TID |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,24-03-2022,24-03-2022,,,10,OPD,
3277,24-03-2022,kasoa,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ]",,,,24-03-2022,24-03-2022,,,20,OPD,
3278,24-03-2022,tetegu,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"G71.9 [Primary disorder of muscle, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], DICLOFENAC TABLET[ LOFNAC | 100MG | Tablet | BDS |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], DICLOFENAC TABLET[ LOFNAC | 100MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,24-03-2022,24-03-2022,,,10,OPD,
3279,24-03-2022,Kasoa High Tension ,27 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,F06.4 [Organic anxiety disorder]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NAT B[ NAT B |  | Capsule ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET[ VALIUM | 10MG | Tablet ]",student,,24-03-2022,24-03-2022,,,20,OPD,
3286,24-03-2022,mallam ,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,
3293,24-03-2022,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], PREGABALIN[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], PREGABALIN[ PREGABALIN | 75MG | Capsule ]",,,24-03-2022,24-03-2022,,,20,OPD,
3305,24-03-2022,awoshie,54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"J20.9 [Acute bronchitis, unspecified]  ==> NEW, E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], DREZ [ DREZ OINTMENT | 10G | Ointment | BDS |  For 7 Days  ], SIMPLE LIMTUS ADULT[ SIMPLE LINTUS ADULT | 100ML | Mixture | TID |  For 5 Days  ], AMOXICILLIN CAPSULE[ AMOXICILIN | 500MG | Capsule | TID |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], DREZ [ DREZ OINTMENT | 10G | Ointment ], SIMPLE LIMTUS ADULT[ SIMPLE LINTUS ADULT | 100ML | Mixture ], AMOXICILLIN CAPSULE[ AMOXICILIN | 500MG | Capsule ]",,,24-03-2022,24-03-2022,,,20,OPD,
3308,24-03-2022,kasoa,66 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,24-03-2022,24-03-2022,,,30,OPD,
3316,24-03-2022,kasoa,76 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ], AMITRIPTYLINE TABLET[ AMITRIPTYLINE | 25MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,
3327,24-03-2022,DJAMA  GBAWE,78 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I15.2 [Hypertension secondary to endocrine disorders]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet | Daily |  For 3 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet ]",,,24-03-2022,24-03-2022,,,30,OPD,
3332,24-03-2022,dansoman,69 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ]",,,24-03-2022,24-03-2022,,,60,OPD,
3340,24-03-2022,new bortianor red top,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, K20. [Oesophagitis]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ]",,,24-03-2022,24-03-2022,,,10,OPD,
3365,24-03-2022,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","I10. [Essential (primary) hypertension]  ==> NEW, N34.1 [Nonspecific urethritis]  ==> NEW",No,Non-Insured,"NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], ATENOLOL TABLET[ ATENOLOL | 50MG | Tablet | OD |  For 60 Days  ]","NAT B[ NAT B |  | Capsule ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], ATENOLOL TABLET[ ATENOLOL | 50MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,
3377,24-03-2022,korkorbitey,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,
3383,24-03-2022,mccarthy,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, G71.8 [Other primary disorders of muscles]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], OSTEOCARE[ OSTEOCARE |  | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], OSTEOCARE[ OSTEOCARE |  | Tablet ]",,,24-03-2022,24-03-2022,,,10,OPD,
3386,24-03-2022,SCC,61 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], SECNIDAZOLE TABLET 500MG[ SECNIDAZOLE | 500MG | Tablet | Daily |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET[ CIPROFLOXACIN | 500MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ], SECNIDAZOLE TABLET 500MG[ SECNIDAZOLE | 500MG | Tablet ]",,,24-03-2022,24-03-2022,,,10,OPD,
3423,24-03-2022,ABLEKUMAH-AGAPE,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,MR-10A-G5-230
3489,24-03-2022,odorkor,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ATENOLOL TABLET[ ATENOLOL | 100MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET[ ATENOLOL | 100MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,24-03-2022,24-03-2022,,,10,OPD,
3503,24-03-2022,"NEW BORTIANOR
LANE 2",53 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,E08.610 [Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,,,24-03-2022,24-03-2022,,,20,OPD,
3516,24-03-2022,"ABLEKUMA , ",52 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I15.2 [Hypertension secondary to endocrine disorders]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,24-03-2022,24-03-2022,,,60,OPD,
3642,24-03-2022,AKWELEY NEW TOWN,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,24-03-2022,24-03-2022,,,10,OPD,
3671,24-03-2022,weija,65 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,24-03-2022,24-03-2022,,,20,OPD,
3705,24-03-2022,ablekuman,69 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Non-Insured,,,,,24-03-2022,24-03-2022,,,10,OPD,
3793,23-03-2022,oblogo school,83 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.7 [Insulin-dependent diabetes mellitus: With multiple complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, G71.9 [Primary disorder of muscle, unspecified]  ==> NEW",No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], OSTEOCARE[ OSTEOCARE |  | Tablet | OD |  For 28 Days  ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], OSTEOCARE[ OSTEOCARE |  | Tablet ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,23-03-2022,23-03-2022,,,60,OPD,
3798,23-03-2022,"SOWUTUOM 
VRA",57 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ]",TRAD,,23-03-2022,23-03-2022,,,50,OPD,
3831,23-03-2022,KASOA-OCOLOMBA,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08628 [Diabetes mellitus due to underlying condition with other skin complications]  ==> NEW,I27.0 [Primary pulmonary hypertension]  ==> NEW,No,Insured,"INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | TDS |  For 3 Days  ], POVIDONE IODINE AQUEOUS[ POVIDONE IODINE AQUEOUS | 1% 100ML | Solution | TDS |  For 1 Days  ], PARACETAMOL[ PARACETAMOL | 1G | Infusion | TDS |  For 3 Days  ], CLINDAMYCIN INJECTION[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 3 Days  ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule | BID |  For 3 Days  ], Normal Saline[  | 500ML | Infusion | TID |  For 3 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | TDS |  For 3 Days  ]","INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ], POVIDONE IODINE AQUEOUS[ POVIDONE IODINE AQUEOUS | 1% 100ML | Solution ], PARACETAMOL[ PARACETAMOL | 1G | Infusion ], CLINDAMYCIN INJECTION[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], DICLOFENAC CAPSULE [ DICLOFENAC | 75MG | Capsule ], Normal Saline[  | 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ]",,,23-03-2022,23-03-2022,,,0,OPD,
3865,23-03-2022,weija,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | BDS |  For 60 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,23-03-2022,23-03-2022,,,20,OPD,
3879,23-03-2022,TETEGU,52 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, K8500 [Idiopathic acute pancreatitis without necrosis or infection]  ==> OLD, M10.9 [Gout, unspecified]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,,,,,23-03-2022,23-03-2022,,,10,OPD,
3900,23-03-2022,awoshie,86 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",,,23-03-2022,23-03-2022,,,20,OPD,
3967,23-03-2022,KWASHIMAN,39 Year(s),Female,ANC CLINIC ,ANC Consultation,,No Outcome,NA ,"O24415 [Gestational diabetes mellitus in pregnancy, controlled by oral hypoglycemic drugs]  ==> NEW",,No,Insured,,,,,23-03-2022,23-03-2022,,,0,OPD,
4089,23-03-2022,GBAWE,35 Year(s),Female,ANC CLINIC ,ANC Consultation,,No Outcome,NA ,"O24415 [Gestational diabetes mellitus in pregnancy, controlled by oral hypoglycemic drugs]  ==> NEW",,No,Insured,,,FOOD VENDIR,,23-03-2022,23-03-2022,,,0,OPD,
4129,23-03-2022,gbawe cp,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"Normal Saline[  | 500ML | Infusion | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION[ DEXTROSE SALINE | 10%+0.18% 250ML | Infusion | Stat |  For 1 Days  ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection | Stat |  For 1 Days  ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet | BDS |  For 1 Days  ]","Normal Saline[  | 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION[ DEXTROSE SALINE | 10%+0.18% 250ML | Infusion ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection ], CEFUROXIME TABLET[ CEFUROXIME | 500MG | Tablet ]",,,23-03-2022,23-03-2022,,,130,OPD,
4141,23-03-2022,gbawe,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ATENOLOL TABLET[ ATENOLOL | 50MG | Tablet | OD |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET[ ATENOLOL | 50MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ]",,,23-03-2022,23-03-2022,,,10,OPD,
4152,23-03-2022,"gbawe
",71 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,23-03-2022,23-03-2022,,,10,OPD,
4342,22-03-2022,SANTA MARIA,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, L03032 [Cellulitis of left toe]  ==> NEW, E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], PREGABALIN[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], PREGABALIN[ PREGABALIN | 75MG | Capsule ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet ]",TRADER,,22-03-2022,22-03-2022,,,20,OPD,
4354,22-03-2022,TUBA JUNCTION ,61 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,A0225 [Salmonella pyelonephritis]  ==> NEW,No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture | TID |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture ]",driver,,22-03-2022,22-03-2022,,,60,OPD,
4360,22-03-2022,AMANFRO-RIVER SIDE,67 Year(s),Female,,,,No Outcome,NA ,E08621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID  [ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BID |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], ASCORBIC ACID  [ VITAMIN C | 100 | Tablet ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], AMOXICILLIN+CLAVULANIC ACID[ AMOKSICLAV | 875MG +125MG | Tablet ]",,,22-03-2022,22-03-2022,,,10,OPD,
4372,22-03-2022,GBAWE,75 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, Z86718 [Personal history of other venous thrombosis and embolism]  ==> OLD, R00.1 [Bradycardia, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,22-03-2022,22-03-2022,,,10,OPD,
4405,22-03-2022,weija,62 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], METFORMIN[ DIAMET | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ]",,,22-03-2022,22-03-2022,,,20,OPD,
4413,22-03-2022,mallam,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,22-03-2022,22-03-2022,,,20,OPD,
4423,22-03-2022,oblogo,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ], DICLOFENAC[ LOFNAC | 100MG | Tablet | BID |  For 5 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], DICLOFENAC[ LOFNAC | 100MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,22-03-2022,22-03-2022,,,20,OPD,
4433,22-03-2022,mallam,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,22-03-2022,22-03-2022,,,20,OPD,
4447,22-03-2022,kasoa,67 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,22-03-2022,22-03-2022,,,10,OPD,
4456,22-03-2022,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"G71.9 [Primary disorder of muscle, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | TID |  For 5 Days  ]",,,,22-03-2022,22-03-2022,,,20,OPD,
4550,22-03-2022,NSAKINA,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"H40051 [Ocular hypertension, right eye]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]",,,,22-03-2022,22-03-2022,,,20,OPD,
4602,22-03-2022,WEIJA. WHITE CROSS,58 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0822 [Diabetes mellitus due to underlying condition with diabetic chronic kidney disease]  ==> NEW,"H40051 [Ocular hypertension, right eye]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, M1610 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ]",,,22-03-2022,22-03-2022,,,20,OPD,
4637,22-03-2022,anyaa,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, G71.9 [Primary disorder of muscle, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], ATORVASTATIN TABLET[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,22-03-2022,22-03-2022,,,10,OPD,
4930,21-03-2022,KASOA-OCOLOMBA,55 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13622 [Other specified diabetes mellitus with other skin ulcer]  ==> NEW,,No,Insured,"DREZ [ DREZ  | 100ML | Solution | OD |  For 7 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BDS |  For 7 Days  ]","DREZ [ DREZ  | 100ML | Solution ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule ]",,,21-03-2022,21-03-2022,,,10,OPD,
4950,21-03-2022,dankuman,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"M10.9 [Gout, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,21-03-2022,21-03-2022,,,20,OPD,
4956,21-03-2022,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  | BDS |  For 60 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  ]",,,21-03-2022,21-03-2022,,,20,OPD,
4962,21-03-2022,tetegu,45 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ]",,,21-03-2022,21-03-2022,,,20,OPD,
5032,21-03-2022,ANYAA,39 Year(s),Female,ANC CLINIC ,ANC Consultation,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Insured,,,,,21-03-2022,21-03-2022,,,0,OPD,
5095,21-03-2022,JOHN TEYE,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, K8501 [Idiopathic acute pancreatitis with uninfected necrosis]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,21-03-2022,21-03-2022,,,10,OPD,
5119,21-03-2022,"FAN MILK 
ABLEKUMA",79 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, E16.8 [Other specified disorders of pancreatic internal secretion]  ==> NEW, M1710 [Unilateral primary osteoarthritis, unspecified knee]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",pension,,21-03-2022,21-03-2022,,,60,OPD,
5154,21-03-2022,upper weija,78 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,21-03-2022,21-03-2022,,,20,OPD,
5157,21-03-2022,new bortiano,30 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 30 Days  ]","LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,21-03-2022,21-03-2022,,,20,OPD,
5163,21-03-2022,ablekuman,66 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",,,21-03-2022,21-03-2022,,,20,OPD,
5171,21-03-2022,gbawe,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,21-03-2022,21-03-2022,,,20,OPD,
5619,18-03-2022,tuba,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,18-03-2022,18-03-2022,,,10,OPD,
5637,18-03-2022,kasoa-peace town,94 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW",No,Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",pension,,18-03-2022,18-03-2022,,,10,OPD,
5657,18-03-2022,"GBAWE , TELECOM",70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], Normal Saline[  | 500ML | Infusion | PRN |  For 1 Days  ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], Normal Saline[  | 500ML | Infusion ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ]",,,18-03-2022,18-03-2022,,,60,OPD,
5682,18-03-2022,"KASOA , TOP HILL ",76 Year(s),Female,,,,No Outcome,NA ,E13621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, G4700 [Insomnia, unspecified]  ==> NEW",No,Insured,DIAZEPAM [ DIAZEPAM | 5MG | Tablet | Every other evening |  For 5 Days  ],DIAZEPAM [ DIAZEPAM | 5MG | Tablet ],,,18-03-2022,18-03-2022,,,10,OPD,
5702,18-03-2022,ABLEKUMAH-JOURMAN,77 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, M1612 [Unilateral primary osteoarthritis, left hip]  ==> NEW, Z86718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 30 Days  ]",,pension,,18-03-2022,18-03-2022,,,50,OPD,
5722,18-03-2022,Ablekuma ,49 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | Stat |  For 1 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,Self Employed,,18-03-2022,18-03-2022,,,50,OPD,
5794,18-03-2022,awoshie,79 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I160 [Hypertensive urgency]  ==> NEW,No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], Normal Saline[  | 500ML | Infusion | PRN |  For 1 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ], Normal Saline[  | 500ML | Infusion ]",TRADER,,18-03-2022,18-03-2022,,,20,OPD,
5831,18-03-2022,MALLAM ,50 Year(s),Male,PHYSIOTHERAPY ,General Consultation Adult,,No Outcome,NA ,E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,,No,Non-Insured,GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 14 Days  ],GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ],,,18-03-2022,18-03-2022,,,50,OPD,
5896,18-03-2022,"BORTIANOR
BROADCASTING",48 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E083399 [Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye]  ==> NEW","H40051 [Ocular hypertension, right eye]  ==> NEW",No,Insured,"TIMOLOL MALEATE [ EPITIMOL | 0.05% 5G | Drops | BID |  For 30 Days  ], DICLOFENAC[ EPIFENAC | 10ML | Drops | TID |  For 30 Days  ]",,TRADER,,18-03-2022,18-03-2022,,,10,OPD,
5945,18-03-2022,BORTIANOR HILLS,46 Year(s),Male,,,,No Outcome,NA ,E13621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"IRON(III)POLYMALTOSE COMPLEX[ FERRUM |  | Capsule | OD |  For 30 Days  ], ASCORBIC ACID  [ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ]",,,,18-03-2022,18-03-2022,,,10,OPD,
6154,17-03-2022,upper weija,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE ()[ AMLODIPINE | 5MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE ()[ AMLODIPINE | 5MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ]",,,17-03-2022,17-03-2022,,,20,OPD,
6174,17-03-2022,"SCC, BROADCASTING",53 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BID |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID[ VITAMIN C | 500MG | Tablet | OD |  For 30 Days  ], CLINDAMYCIN[ (DALACIN C)  | 300MG/2ML | Injection | QID |  For 30 Days  ]",,,,17-03-2022,17-03-2022,,,0,OPD,
6188,17-03-2022,"ALIU MAHAMA ROAD
DANSOMAN ",74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], Normal Saline[  | 500ML | Infusion | PRN |  For 1 Days  ]","INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ], Normal Saline[  | 500ML | Infusion ]",,,17-03-2022,17-03-2022,,,20,OPD,
6290,17-03-2022,Palace Town Awoshie,64 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, I64 [Stroke, not specified as haemorrhage or infarction]  ==> OLD",No,Non-Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,Retired,,17-03-2022,17-03-2022,,,10,OPD,
6421,17-03-2022,malla cp,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,"1, INFECTED RT BIG TOE WOUND
2. DIABETES MELLITUS  ",E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,,,,,17-03-2022,17-03-2022,,,10,OPD,
6427,17-03-2022,tuba,69 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,,,,,17-03-2022,17-03-2022,,,10,OPD,
6464,17-03-2022,"GBAWE , SOLID ROCK",72 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, I64 [Stroke, not specified as haemorrhage or infarction]  ==> OLD",No,Non-Insured,,,,,17-03-2022,17-03-2022,,,50,OPD,
6465,17-03-2022,suwotuw,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,17-03-2022,17-03-2022,,,50,OPD,
6469,17-03-2022,weija new twon,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,"1. HYPERGLYCAEMIA IN DM
          R/O DKA
2. KNOWN KOCHS (ON RX) ",E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | PRN |  For 30 Days  ]","GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  ]",,,17-03-2022,17-03-2022,,,20,OPD,
6488,17-03-2022,gbawe cp,62 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,17-03-2022,17-03-2022,,,10,OPD,
6681,16-03-2022,kasoa galelia,54 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, R00.0 [Tachycardia, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], ATENOLOL[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], ATENOLOL[ ATENOLOL | 100MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,16-03-2022,16-03-2022,,,50,OPD,
6783,16-03-2022,MALLAM,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,16-03-2022,16-03-2022,,,20,OPD,
6811,16-03-2022,kasoa-peace town,94 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E08621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,"TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 7 Days  ], DREZ [ DREZ  | 100ML | Solution | OD |  For 7 Days  ]",,pension,,16-03-2022,16-03-2022,,,10,OPD,
6848,16-03-2022,AMANFRO-BRIGADE,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86718 [Personal history of other venous thrombosis and embolism]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,16-03-2022,16-03-2022,,,20,OPD,
7008,16-03-2022,OFORIKROM ,70 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,G63.6* [Polyneuropathy in other musculoskeletal disorders]  ==> NEW,No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NAT B[ NAT B |  | Capsule ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,16-03-2022,16-03-2022,,,10,OPD,
7103,16-03-2022,kasoa,53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,URETHRITIS ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CEFUROXIME [ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], CEFUROXIME [ CEFUROXIME | 500MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,16-03-2022,16-03-2022,,,20,OPD,
7331,15-03-2022,kasoa,53 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ]",,,15-03-2022,15-03-2022,,,10,OPD,
7366,15-03-2022,KASOA DOMEABRA,60 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E1110 [Type 2 diabetes mellitus with ketoacidosis without coma]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Non-Insured,"NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]",,,,15-03-2022,15-03-2022,,,50,OPD,
7368,15-03-2022,ablekuman,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, B33.0 [Epidemic myalgia]  ==> NEW",No,Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ACECLOFENAC(ZULU)[ ACECLOFENAC(ZULU) | 100MG | Tablet | BID |  For 7 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], ACECLOFENAC(ZULU)[ ACECLOFENAC(ZULU) | 100MG | Tablet ]",,,15-03-2022,15-03-2022,,,20,OPD,
7370,15-03-2022,"NYAMESTE 
LAPAZ",33 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,15-03-2022,15-03-2022,,,20,OPD,
7399,15-03-2022,kasoa,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"PREGABALIN[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","PREGABALIN[ PREGABALIN | 75MG | Capsule ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,15-03-2022,15-03-2022,,,20,OPD,
7429,15-03-2022,JOHN TEYE,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,15-03-2022,15-03-2022,,,10,OPD,
7530,15-03-2022,"AWOSHIE, A LANG",76 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E1140 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,,,BUTCHER,,15-03-2022,15-03-2022,,,10,OPD,
7550,15-03-2022,KWASHIEMAN,78 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"M1612 [Unilateral primary osteoarthritis, left hip]  ==> NEW",No,Insured,,,pension,,15-03-2022,15-03-2022,,,20,OPD,
7556,15-03-2022,tabola,79 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,B33.0 [Epidemic myalgia]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], PARACETAMOL[ PARACETAMOL | 1G | Suppository | TDS |  For 5 Days  ], MULTIVITAMIN[ MULTIVITAMIN |  | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], PARACETAMOL[ PARACETAMOL | 1G | Suppository ], MULTIVITAMIN[ MULTIVITAMIN |  | Tablet ]",Pensioner,,15-03-2022,15-03-2022,,,20,OPD,
7591,15-03-2022,"GBAWE 
NEAR TIM SPOT ",59 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E1142 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NAT B[ NAT B |  | Capsule ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",WELDER,,15-03-2022,15-03-2022,,,10,OPD,
7592,15-03-2022,tetegu,45 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], NAT B[ NAT B |  | Capsule ]",BUSINESS PERSON,,15-03-2022,15-03-2022,,,60,OPD,
7602,15-03-2022,malla,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,15-03-2022,15-03-2022,,,20,OPD,
7731,15-03-2022,Kasoa choice ,71 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,"SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METRONIDAOLE[ METRONIDAOLE | 500MG 100ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], METRONIDAOLE[ METRONIDAOLE | 500MG 100ML | Infusion ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection ]",FARMER,,15-03-2022,15-03-2022,,,50,OPD,
7850,14-03-2022,papase,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL [ LISINOPRIL | 5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE ()[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ]",,,,14-03-2022,14-03-2022,,,10,OPD,
7883,14-03-2022,kasoa new twon,64 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ]",,,14-03-2022,14-03-2022,,,20,OPD,
7893,14-03-2022,apleku,70 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,14-03-2022,14-03-2022,,,20,OPD,
7925,14-03-2022,weija,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,14-03-2022,14-03-2022,,,10,OPD,
8071,14-03-2022,tuba,71 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], FUROSEMIDE [ FUROSEMIDE | 40MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], FUROSEMIDE [ FUROSEMIDE | 40MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,14-03-2022,14-03-2022,,,10,OPD,
8393,13-03-2022,KASOA  IRON  CITY,53 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0843 [Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy]  ==> NEW,,No,Non-Insured,"CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 14 Days  ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], MULTIVITAMIN[ MULTIVITAMIN |  | Tablet | TDS |  For 14 Days  ]","CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet ], MULTIVITAMIN[ MULTIVITAMIN |  | Tablet ]",Self Employed,,13-03-2022,13-03-2022,,,50,OPD,
8681,11-03-2022,odorkor,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW, E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ]","LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,11-03-2022,11-03-2022,,,20,OPD,
8687,11-03-2022,kasoa tuba,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,11-03-2022,11-03-2022,,,20,OPD,
8700,11-03-2022,ODORKOR  OFFICIAL TOWN,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,,,Unemployed,,11-03-2022,11-03-2022,,,20,OPD,
8716,11-03-2022,MALLAM ,50 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 14 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,11-03-2022,11-03-2022,,,50,OPD,
8719,11-03-2022,GBAWE,68 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ASCORBIC ACID  [ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BID |  For 30 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], ASCORBIC ACID  [ VITAMIN C | 100 | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule ]",TRADER,,11-03-2022,11-03-2022,,,10,OPD,
8741,11-03-2022,KWASHIEMAN,78 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"M1732 [Unilateral post-traumatic osteoarthritis, left knee]  ==> NEW, Z86718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,"CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",pension,,11-03-2022,11-03-2022,,,20,OPD,
8772,11-03-2022,MCCARTHY ,83 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"Z8711 [Personal history of peptic ulcer disease]  ==> NEW, E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CLARITHROMYCIN [ CLARITHROMYCIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], HYOSCINE-N-BUTYLBROMIDE[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN [ CLARITHROMYCIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], HYOSCINE-N-BUTYLBROMIDE[ BUSCOPAN | 10MG | Tablet ]",Retired,,11-03-2022,11-03-2022,,,10,OPD,
8780,11-03-2022,kwashieman,84 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW, J4521 [Mild intermittent asthma with (acute) exacerbation]  ==> NEW",No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], SALBUTAMOL [ SALBUTAMOL | 4MG | Tablet | TID |  For 14 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], SALBUTAMOL [ SALBUTAMOL | 4MG | Tablet ]",,,11-03-2022,11-03-2022,,,10,OPD,
8931,11-03-2022,"APLAKU , PALM BRFOS",62 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  | PRN |  For 1 Days  ], METRONIDAOLE[ METRONIDAOLE | 500MG 100ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]","SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], INSULIN(SOBUBLE) ()[ INSULIN(SOBUBLE) |  |  ], METRONIDAOLE[ METRONIDAOLE | 500MG 100ML | Infusion ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",TRDAER,,11-03-2022,11-03-2022,,,50,OPD,
8972,11-03-2022,QUEEN CITY KASOA OFANKOR,53 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,Z8631 [Personal history of diabetic foot ulcer]  ==> OLD,No,Insured,"INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], Normal Saline[  | 500ML | Infusion | PRN |  For 1 Days  ]","INSULIN(SOBUBLE)[ ACTRAPID | 100IU/10ML | Injection ], Normal Saline[  | 500ML | Infusion ]",Self Employed,,11-03-2022,11-03-2022,,,50,OPD,
9019,10-03-2022,"KWASHIEMAN , HAPPY KIDS ",41 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | OD |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ]",,,10-03-2022,10-03-2022,,,10,OPD,
9026,10-03-2022,BORTIANOR ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,10-03-2022,10-03-2022,,,10,OPD,
9045,10-03-2022,bubueshie,55 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BDS |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], PIOGLITAZONE[ PIOGLITAZONE | 15MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule ]",,,10-03-2022,10-03-2022,,,20,OPD,
9058,10-03-2022,tetegu,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"H40052 [Ocular hypertension, left eye]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,10-03-2022,10-03-2022,,,20,OPD,
9065,10-03-2022,weija sch jut,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 60 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",Self Employed,,10-03-2022,10-03-2022,,,20,OPD,
9091,10-03-2022,SOWUTUOM  ROMAN HILL,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E089 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> OLD, G8921 [Chronic pain due to trauma]  ==> NEW, G58.9 [Mononeuropathy, unspecified]  ==> NEW",No,Non-Insured,"TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 10 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 10 Days  ]","TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ], METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,10-03-2022,10-03-2022,,,50,OPD,
9104,10-03-2022,weija,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,MYALGIA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 90 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,10-03-2022,10-03-2022,,,10,OPD,
9111,10-03-2022,mallam jut,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,10-03-2022,10-03-2022,,,20,OPD,
9116,10-03-2022,mallam,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,URETHRITIS ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CEFUROXIME [ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], CEFUROXIME [ CEFUROXIME | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ]",,,10-03-2022,10-03-2022,,,20,OPD,
9118,10-03-2022,"SOWUTUOM 
CHOP BAR",73 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, L29.9 [Pruritus, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], LISINOPRIL[ LISINOPRIL | 20MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 60 Days  ], CETIRIZINE[ CETIRIZINE | 10MG | Tablet | Daily |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL[ LISINOPRIL | 20MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], CETIRIZINE[ CETIRIZINE | 10MG | Tablet ]",,,10-03-2022,10-03-2022,,,20,OPD,
9125,10-03-2022,dansoman,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,PERIPHERAL NEUROPATHY ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ]",,,10-03-2022,10-03-2022,,,10,OPD,
9137,10-03-2022,apam,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",,,10-03-2022,10-03-2022,,,20,OPD,
9226,10-03-2022,CHOICE,37 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",TRADER,,10-03-2022,10-03-2022,,,10,OPD,
9237,10-03-2022,new bortianor,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 60 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",,,10-03-2022,10-03-2022,,,10,OPD,
9248,10-03-2022,anyaa nic,42 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,CORYZA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ], CETIRIZINE[ CETIRIZINE | 10MG | Tablet | PM |  For 3 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PARACETAMOL [ PARACETAMOL | 500MG | Tablet ], CETIRIZINE[ CETIRIZINE | 10MG | Tablet ]",TRADER,,10-03-2022,10-03-2022,,,10,OPD,
9298,10-03-2022,ABLEKUMAH-ODUMA,50 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","I15.9 [Secondary hypertension, unspecified]  ==> NEW, B0222 [Postherpetic trigeminal neuralgia]  ==> OLD, L30.3 [Infective dermatitis]  ==> OLD, B20.3 [HIV disease resulting in other viral infections]  ==> NEW",No,Non-Insured,"CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 15 Days  ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | OD |  For 15 Days  ], METRONIDAZOLE GEL[ METROGEL | 20G | Gel | BDS |  For 14 Days  ], AMITRIPTYLINE[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], ASCORBIC ACID [ (VITAMIN C) | 1000MG | Tablet | OD |  For 14 Days  ]","CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ], METRONIDAZOLE GEL[ METROGEL | 20G | Gel ], AMITRIPTYLINE[ AMITRIPTYLINE | 25MG | Tablet ], ASCORBIC ACID [ (VITAMIN C) | 1000MG | Tablet ]",,,10-03-2022,10-03-2022,,,50,OPD,
9396,10-03-2022,awoshie fan milk,61 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], AMITRIPTYLINE[ AMITRIPTYLINE | 25MG | Tablet | PM |  For 15 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], AMITRIPTYLINE[ AMITRIPTYLINE | 25MG | Tablet ]",,,10-03-2022,10-03-2022,,,10,OPD,
9547,09-03-2022,ANYAA,68 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,09-03-2022,09-03-2022,,,10,OPD,
9582,09-03-2022,kasoa,32 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]",,,,09-03-2022,09-03-2022,,,20,OPD,
9651,09-03-2022,mallam bola raod,81 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ]",,,09-03-2022,09-03-2022,,,20,OPD,
9725,09-03-2022,weija,62 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  | Stat |  For 1 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  ]",,,09-03-2022,09-03-2022,,,30,OPD,
9726,09-03-2022,NIC-AWOSHIE,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD, I15.8 [Other secondary hypertension]  ==> NEW","I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"ATENOLOL [ ATENOLOL | 50MG | Tablet | Daily |  For 0 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 0 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], DICLOFENAC [ DICLOFENAC | 75MG | Capsule | BDS |  For 7 Days  ], DREZ SOLUTION 100ML ()[ DREZ SOLUTION 100ML |  |  | OD |  For 14 Days  ]",,,,09-03-2022,09-03-2022,,,10,OPD,
9764,09-03-2022,GBAWE,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, Z8711 [Personal history of peptic ulcer disease]  ==> NEW, B54 [Unspecified malaria]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CLARITHROMYCIN [ CLARITHROMYCIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet | BID |  For 3 Days  ], HYOSCINE-N-BUTYLBROMIDE[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN [ CLARITHROMYCIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], ARTERMETHER+LUMEFANTRINE(6')[ COARTEM | 80/480MG | Tablet ], HYOSCINE-N-BUTYLBROMIDE[ BUSCOPAN | 10MG | Tablet ]",,,09-03-2022,09-03-2022,,,10,OPD,
9766,09-03-2022,TANTRA HILL,76 Year(s),Male,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","B00.9 [Herpesviral infection, unspecified]  ==> NEW, B0222 [Postherpetic trigeminal neuralgia]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], PREGABALIN[ PREGABALIN | 75MG | Capsule | Nocte |  For 15 Days  ], CETIRIZINE[ CETIRIZINE | 10MG | Tablet | Nocte |  For 10 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ]",,Unemployed,,09-03-2022,09-03-2022,,,60,OPD,
9925,09-03-2022,"MALLAM-STATION
50652/17
MR-12A-B7-89",35 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,IMPAIRED GLUCOSE TOLERANCE ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Insured,,,Teacher,,09-03-2022,09-03-2022,,,10,OPD,
9930,09-03-2022,weija,47 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,,,TRADER,,09-03-2022,09-03-2022,,,20,OPD,
9939,09-03-2022,mataheko ,95 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> OLD, Z86718 [Personal history of other venous thrombosis and embolism]  ==> NEW, I69.4 [Sequelae of stroke, not specified as haemorrhage or infarction]  ==> OLD",No,Insured,"NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], ALKA 5 [ ALKA 5  | 100ML | Syrup | BID |  For 30 Days  ]","NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], ALKA 5 [ ALKA 5  | 100ML | Syrup ]",Unemployed,,09-03-2022,09-03-2022,,,10,OPD,
9977,09-03-2022,awoshie,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Non-Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ]",Self Employed,,09-03-2022,09-03-2022,,,60,OPD,
10076,09-03-2022,weija,62 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,MEDI32A [Hypertension >=12 Yrs]  ==> NEW,No,Insured,,,,,09-03-2022,09-03-2022,,,80,OPD,
10160,08-03-2022,SAMPA   VALLEY   WEIJA,67 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, I30.8 [Other forms of acute pericarditis]  ==> NEW, R00.0 [Tachycardia, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID[ AMOKSICLAV | 1G | Tablet | BID |  For 7 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID[ AMOKSICLAV | 1G | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ]",,,08-03-2022,08-03-2022,,,60,OPD,
10217,08-03-2022,SANTA MARIA AUNTIE AKU,69 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> NEW, Z86718 [Personal history of other venous thrombosis and embolism]  ==> OLD, A0225 [Salmonella pyelonephritis]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], SECNIDAZOLE ()[ SECNIDAZOLE |  |  | Daily AC |  For 1 Days  ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture | BID |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], SECNIDAZOLE ()[ SECNIDAZOLE |  |  ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture ]",,,08-03-2022,08-03-2022,,,10,OPD,
10246,08-03-2022,kokrobite,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,hyperglycaemia in a known DM ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,,,,,08-03-2022,08-03-2022,,,20,OPD,
10260,08-03-2022,"KASOA, OFAAKOR",69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, K8500 [Idiopathic acute pancreatitis without necrosis or infection]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,08-03-2022,08-03-2022,,,20,OPD,
10284,08-03-2022,gbawe,64 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,08-03-2022,08-03-2022,,,20,OPD,
10296,08-03-2022,anyaa market,87 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,,,Unemployed,,08-03-2022,08-03-2022,,,20,OPD,
10311,08-03-2022,accra central police station,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,"HYPERTENSION
DIABETES ",E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,I15.8 [Other secondary hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL [ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], ATENOLOL [ ATENOLOL | 50MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",seamstress,,08-03-2022,08-03-2022,,,20,OPD,
10341,08-03-2022,bubiashie,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet ]",,,08-03-2022,08-03-2022,,,10,OPD,
10404,08-03-2022,mallam station,60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW, S0100XA [Unspecified open wound of scalp, initial encounter]  ==> NEW",No,Insured,"PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ANTI TETANUS SERUM[ ATS | 1500IU/ML | Injection | Stat |  For 1 Days  ], AMOXICILLIN+CLAVULINIC ACID  14\[ AMOXICLAV | 625MG | Tablet | BDS |  For 5 Days  ]","PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], ANTI TETANUS SERUM[ ATS | 1500IU/ML | Injection ], AMOXICILLIN+CLAVULINIC ACID  14\[ AMOXICLAV | 625MG | Tablet ]",,,08-03-2022,08-03-2022,,,10,OPD,
10418,08-03-2022,ablekuma pentecost junction,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ]",,,08-03-2022,08-03-2022,,,20,OPD,
10437,08-03-2022,Amasaman,65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, A0100 [Typhoid fever, unspecified]  ==> NEW",No,Insured,"ATENOLOL[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]","ATENOLOL[ ATENOLOL | 100MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ]",,,08-03-2022,08-03-2022,,,10,OPD,
10450,08-03-2022,kasoa block factory,49 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,"HYPERTENSIVE URGENCY
HYPERGLYCAEMIA IN KNOWN DM ","E083212 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye]  ==> NEW","I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  | Stat |  For 1 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ], METFORMIN[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ], INSULIN(PREMIXED ()[ INSULIN(PREMIXED |  |  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",TRADER,,08-03-2022,08-03-2022,,,20,OPD,
10475,08-03-2022,mc catrthy ,77 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,HICCUPS ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], METOCLOPRAMIDE[ METOCLOPRAMIDE | 10MG | Tablet | BDS |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], METOCLOPRAMIDE[ METOCLOPRAMIDE | 10MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ]",Unemployed,,08-03-2022,08-03-2022,,,20,OPD,
10485,08-03-2022,scc,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"LISINOPRIL[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ]","LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",,,08-03-2022,08-03-2022,,,10,OPD,
10517,08-03-2022,anyaa nic,63 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I15.9 [Secondary hypertension, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], PREGABALIN[ PREGABALIN | 75MG | Capsule | OD |  For 90 Days  ]","NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet ], PREGABALIN[ PREGABALIN | 75MG | Capsule ]",,,08-03-2022,08-03-2022,,,10,OPD,
10546,08-03-2022,liberia camp kasoa,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN[ DIAMET | 500MG | Tablet ],Self Employed,,08-03-2022,08-03-2022,,,20,OPD,
10652,08-03-2022,"WEIJA, DJAMAN",60 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | Daily |  For 60 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection ]",,,08-03-2022,08-03-2022,,,10,OPD,
10670,08-03-2022,WEIJA OLD BARRIER NEAR KINGS UNIVERSITY ,70 Year(s),Male,,,,No Outcome,NA ,E1165 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"PARACETAMOL[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection | OD |  For 1 Days  ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","PARACETAMOL[ PARACETAMOL | 1G | Infusion ], GIVING SET FOR INFUSION[ GIVING SET FOR INFUSION |  | Injection ], CEFTRIAXONE[ CEFTRIAXONE | 1G | Injection ], SODIUM CHLORIDE[ SODIUM CHLORIDE | 0.9% 500ML | Infusion ]",,,08-03-2022,08-03-2022,,,55,OPD,
10695,07-03-2022,"AMANFROM
ZONGO",55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NAT B[ NAT B |  | Capsule ]",,,07-03-2022,07-03-2022,,,20,OPD,
10709,07-03-2022,"KASOA , NYANYANO ",84 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0821 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,"M47.9 [Spondylosis, unspecified]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository ], NAT B[ NAT B |  | Capsule ]",,,07-03-2022,07-03-2022,,,20,OPD,1663/17 MR-6B-E6-38
10716,07-03-2022,TETEGU-NEW SITE,54 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",Z8711 [Personal history of peptic ulcer disease]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], NUGEL [ NUGEL  | 200ML | Suspension | BDS |  For 7 Days  ], NAT B[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL [ NUGEL  | 200ML | Suspension ], NAT B[ NAT B |  | Capsule ]",TRADER,,07-03-2022,07-03-2022,,,20,OPD,2199/22
10736,07-03-2022,"upper weija
station",84 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0842 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,07-03-2022,07-03-2022,,,10,OPD,
10766,07-03-2022,barrier old,65 Year(s),Male,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,E08618 [Diabetes mellitus due to underlying condition with other diabetic arthropathy]  ==> NEW,,No,Insured,GLIMEPERIDE [ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ],,,,07-03-2022,07-03-2022,,,10,OPD,
10822,07-03-2022,ABLEKUMA,59 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,Unemployed,,07-03-2022,07-03-2022,,,70,OPD,
11034,04-03-2022,"AWOSHIE, NIC",53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, G4485 [Primary stabbing headache]  ==> NEW, N34.1 [Nonspecific urethritis]  ==> NEW, B18.1 [Chronic viral hepatitis B without delta-agent]  ==> NEW",No,Insured,"TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], CEFUROXIME [ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], HEPTONICA[ HEPTONICA | 330ML | Mixture | TID |  For 14 Days  ], NIBIMA MIXTURE[ NIBIMA MIXTURE | 330ML | Mixture | TID |  For 14 Days  ]",,,,04-03-2022,04-03-2022,,,10,OPD,
11038,04-03-2022,"AMANFROM
ZONGO",55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,04-03-2022,04-03-2022,,,30,OPD,
11118,04-03-2022,TETEGU-JUNCTN NEW SITE,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, K8500 [Idiopathic acute pancreatitis without necrosis or infection]  ==> NEW, A0225 [Salmonella pyelonephritis]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | BID |  For 14 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture | BID |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture ]",housewife,,04-03-2022,04-03-2022,,,10,OPD,
11173,04-03-2022,anyaa nic,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 120 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ]",,,,04-03-2022,04-03-2022,,,20,OPD,
11183,04-03-2022,weija,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 120 Days  ], BENDROFLUAZIDE[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], BENDROFLUAZIDE[ BENDROFLUAZIDE | 2.5MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ]",,,04-03-2022,04-03-2022,,,20,OPD,
11189,04-03-2022,santa marie,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ], BENDROFLUAZIDE[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 120 Days  ]",,,,04-03-2022,04-03-2022,,,60,OPD,
11207,04-03-2022,MALLAM ,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Child,,No Outcome,NA ,"MEDI35A [Ulcer of Skin >=12 Yrs]  ==> NEW, E10622 [Type 1 diabetes mellitus with other skin ulcer]  ==> NEW",,No,Insured,"AMOXICILLIN+CLAVULINIC ACID[ AMOKSICLAV | 1G | Tablet | BID |  For 7 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]",,,,04-03-2022,04-03-2022,,,0,OPD,
11274,04-03-2022,kasoa,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E088 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,04-03-2022,04-03-2022,,,10,OPD,
11288,04-03-2022,"NII BOI TOWN,",76 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, M1710 [Unilateral primary osteoarthritis, unspecified knee]  ==> OLD",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 30 Days  ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], NAT B[ NAT B |  | Capsule ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ], DICLOFENAC [ DICLOFENAC | 100MG | Suppository ]",Unemployed,,04-03-2022,04-03-2022,,,10,OPD,18110/21
11299,04-03-2022,odorkor,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 120 Days  ]",,,,04-03-2022,04-03-2022,,,20,OPD,
11377,04-03-2022,kasoa,44 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E088 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ],,Teacher,,04-03-2022,04-03-2022,,,10,OPD,
11483,03-03-2022,"BORTIANOR-NEW APLAKU
172/22",82 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, M1710 [Unilateral primary osteoarthritis, unspecified knee]  ==> NEW, K27.7 [Peptic ulcer, site unspecified: Chronic without haemorrhage or perforation]  ==> NEW",No,Insured,"NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | BID |  For 14 Days  ], NUGEL - O [ NUGEL - O  | 200ML | Suspension | BID |  For 7 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O [ NUGEL - O  | 200ML | Suspension ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",,,03-03-2022,03-03-2022,,,20,OPD,
11556,03-03-2022,ABLKEUMA ,39 Year(s),Female,ANC CLINIC ,ANC Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,,,TRADER,,03-03-2022,03-03-2022,,,0,OPD,
11557,03-03-2022,nurses quarters,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0829 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, E098 [Drug or chemical induced diabetes mellitus with unspecified complications]  ==> NEW",No,Insured,"AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ], AMOXICILLIN+CLAVULINIC ACID ()[ OTHERS | 625MG | Tablet | BID |  For 7 Days  ], DREZ [ DREZ OINTMENT | 10G | Ointment | BDS |  For 5 Days  ], ANTI TETANUS SERUM[ ATS | 1500IU/ML | Injection | Stat |  For 1 Days  ]","AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], METFORMIN[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID ()[ OTHERS | 625MG | Tablet ], DREZ [ DREZ OINTMENT | 10G | Ointment ], ANTI TETANUS SERUM[ ATS | 1500IU/ML | Injection ]",,,03-03-2022,03-03-2022,,,10,OPD,
11566,03-03-2022,santa maria,90 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0829 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 120 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Daily |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,10,OPD,
11583,03-03-2022,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0829 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, J00 [Acute nasopharyngitis [common cold]]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 120 Days  ], CARBOCISTEINE -ADULT[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TDS |  For 7 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | TDS |  For 10 Days  ]",,,,03-03-2022,03-03-2022,,,10,OPD,
11594,03-03-2022,gbawe top base,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0969 [Drug or chemical induced diabetes mellitus with other specified complication]  ==> NEW,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | Daily |  For 120 Days  ], GLIMEPERIDE[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,10,OPD,
11606,03-03-2022,GBAWE,65 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10 [Essential (primary) hypertension]  ==> OLD, A0225 [Salmonella pyelonephritis]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 30 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | BID |  For 7 Days  ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture | TDS |  For 7 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], MIST POTASSIUM CITRATE[ MIST POT CIT | 200ML | Mixture ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ]",,,03-03-2022,03-03-2022,,,10,OPD,
11614,03-03-2022,AWOSHIE,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"I10 [Essential (primary) hypertension]  ==> NEW, M1711 [Unilateral primary osteoarthritis, right knee]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",,,03-03-2022,03-03-2022,,,50,OPD,
11615,03-03-2022,new aplaku,71 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0869 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,20,OPD,
11628,03-03-2022,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN(PREMIXED)30/70[ MIXTARD | 100IU/10ML | Injection | BID |  For 120 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,30,OPD,
11629,03-03-2022,OTEBU,74 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","M35.3 [Polymyalgia rheumatica]  ==> NEW, I10 [Essential (primary) hypertension]  ==> NEW, B54 [Unspecified malaria]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], ARTEMETHER+LUMEFANTRINE 24's[ ARTEMETHER+LUMEFANTRINE | 20/120MG | Tablet | BID |  For 3 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BDS |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet ], ARTEMETHER+LUMEFANTRINE 24's[ ARTEMETHER+LUMEFANTRINE | 20/120MG | Tablet ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",TRADER,,03-03-2022,03-03-2022,,,20,OPD,
11641,03-03-2022,galilea,70 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ], CARBOCISTEINE -ADULT[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TID |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,20,OPD,
11660,03-03-2022,"WEIJA 
SCHOOL JUNCTION ",69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0841 [Diabetes mellitus due to underlying condition with diabetic mononeuropathy]  ==> NEW,,No,Insured,,,pension,,03-03-2022,03-03-2022,,,10,OPD,
11688,03-03-2022,OLD BARRIER ,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Non-Insured,CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | TID |  For 7 Days  ],CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule ],,,03-03-2022,03-03-2022,,,50,OPD,
11729,03-03-2022,santa maria,79 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], NIFEDIPINE[ NIFECARD XL | 30MG | Tablet | Daily |  For 120 Days  ], LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ]",,,,03-03-2022,03-03-2022,,,20,OPD,
11735,03-03-2022,anyaa,64 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN[ LOSARTAN | 50MG | Tablet | Daily |  For 120 Days  ], METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], AMLODIPINE[ AMLODIPINE | 10MG | Tablet | Daily |  For 120 Days  ], CLINDAMYCIN [ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]",,Pensioner,,03-03-2022,03-03-2022,,,20,OPD,
11756,03-03-2022,"Kasoa,opeikuma",65 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ], PIOGLITAZONE [ PIOGLITAZONE | 30MG | Tablet | Daily |  For 120 Days  ]",,Pensioner,,03-03-2022,03-03-2022,,,20,OPD,
12000,02-03-2022,ABLEKUMAH-PENTECOST PRAYER CAMP,70 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0800 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,D6869 [Other thrombophilia]  ==> NEW,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID (ASPIRIN)[ ACETYLSALICYLIC ACID (ASPIRIN) | 75MG | Tablet | Daily |  For 30 Days  ]",,,,02-03-2022,02-03-2022,,,20,OPD,
12025,02-03-2022,ABLEKUMA,37 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,E08311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,,No,Insured,,,,,02-03-2022,02-03-2022,,,0,OPD,
12029,02-03-2022,KWASHIEMAN,89 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E0840 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","I15.9 [Secondary hypertension, unspecified]  ==> NEW, G8911 [Acute pain due to trauma]  ==> NEW, N34.1 [Nonspecific urethritis]  ==> NEW",No,Non-Insured,"CEFUROXIME [ CEFUROXIME | 500MG | Tablet | BID |  For 7 Days  ], ATENOLOL [ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 7 Days  ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ]","CEFUROXIME [ CEFUROXIME | 500MG | Tablet ], ATENOLOL [ ATENOLOL | 50MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ], TRAMADOL+PARACETAMOL[ DORETA | (37.5+500)MG | Tablet ]",pension,,02-03-2022,02-03-2022,,,50,OPD,
12120,02-03-2022,NIC-AWOSHIE,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,"N34.1 [Nonspecific urethritis]  ==> NEW, I10 [Essential (primary) hypertension]  ==> NEW",No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], ATENOLOL [ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], ATENOLOL [ ATENOLOL | 50MG | Tablet ]",,,02-03-2022,02-03-2022,,,20,OPD,
12192,02-03-2022,"WEIJA 
PRESBY PRIMARY",57 Year(s),Female,HYPERTENSIVE CLINIC,General Consultation Adult,,No Outcome,NA ,E0865 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 120 Days  ], NIFEDIPINE RETARD[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 120 Days  ], BENDROFLUAZIDE[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 120 Days  ], ATORVASTATIN[ ATORVASTATIN | 20MG | Tablet | Daily |  For 120 Days  ]",,,,02-03-2022,02-03-2022,,,10,OPD,
12250,02-03-2022,"BLOCKFACTORY
SCC",59 Year(s),Female,HYPERTENSIVE CLINIC,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BID |  For 120 Days  ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 120 Days  ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel | BID |  For 120 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE[ GLIBENCLAMIDE | 5MG | Tablet ], DICLOFENAC [ DICLOFENAC GEL | 30G | Gel ]",,,02-03-2022,02-03-2022,,,10,OPD,
12326,02-03-2022,WEIJAA,67 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,"I11.9 [Hypertensive heart disease without (congestive) heart failure]  ==> NEW, A0100 [Typhoid fever, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet | BDS |  For 14 Days  ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], NUGEL [ NUGEL  | 200ML | Suspension | TID |  For 7 Days  ]","METFORMIN[ DIAMET | 500MG | Tablet ], LISINOPRIL[ LISINOPRIL | 10MG | Tablet ], CIPROFLOXACIN [ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE[ METRONIDAZOLE | 400MG | Tablet ], OMEPRAZOLE[ OMEPRAZOLE | 20MG | Capsule ], NUGEL [ NUGEL  | 200ML | Suspension ]",,,02-03-2022,02-03-2022,,,50,OPD,
12477,02-03-2022,WEIJA,43 Year(s),Female,,,,No Outcome,NA ,E1101 [Type 2 diabetes mellitus with hyperosmolarity with coma]  ==> NEW,,No,Insured,CEFUROXIME[ CEFUROXIME | 750MG | Injection | Stat |  For 1 Days  ],,TRADER,,02-03-2022,02-03-2022,,,30,OPD,
12693,01-03-2022,KWASHIEMAN,78 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E0810 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,I10 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NAT B[ NAT B |  | Capsule | Daily |  For 30 Days  ], PREGABALIN[ PREGABALIN | 75MG | Capsule | BDS |  For 7 Days  ]",,pension,,01-03-2022,01-03-2022,,,20,OPD,
